Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Nepafenac bulk supplier for pharma manufacturers

Nepafenac 0.1%, 0.3% Suppliers & Bulk Manufacturers

Available Forms: Eye Drops

Available Strengths: 0.1%, 0.3%

Reference Brands: Nevanac (USA/EU), Ilevro (USA/EU)

Category: Opthalmology

Nepafenac is available as ophthalmic suspension in strengths 0.1% and 0.3%, supplied in sterile dropper bottles for ocular use. Short description: Nepafenac is a nonsteroidal anti-inflammatory drug used in the eye to reduce pain and inflammation associated with cataract surgery. It is a prodrug that converts to amfenac in ocular tissues, providing targeted anti-inflammatory effects. It is usually prescribed for short-term postoperative management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Nepafenac — third party manufacturing & bulk supply

Nepafenac 0.1%, 0.3% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Nepafenac listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Nepafenac →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Nepafenac is used to reduce pain and inflammation in the eye following cataract surgery. It works as a non-steroidal anti-inflammatory drug (NSAID) that helps control postoperative swelling and discomfort.

Nepafenac is made from nepafenac, a prodrug that converts into amfenac inside the eye to provide targeted anti-inflammatory effects.

Common trade names include Nevanac and Ilevro.

Nevanac and Ilevro are marketed by Alcon Laboratories.

The generic name is nepafenac.

Well-known brand names include Nevanac and Ilevro.

Nepafenac is manufactured in regions such as India, the USA, and EU territories by branded ophthalmic manufacturers and approved generic producers.

Related Products

Artificial Tears

Strength:
0.3% to 1%

Form: Eye Drops/ Eye Gel/ Eye ointment

Reference Brands: Refresh Tears (USA/LATAM), Hylo-Tear (EU), Refresh Liquigel (India)

View Details
Tetrahydrozoline Hydrochloride

Strength:
0.05%

Form: Eye Drops

Reference Brands: Visine (USA/EU / LATAM), Ocuvis (India)

View Details
Faricimab

Strength:
6 mg/0.05 mL

Form: Injection

Reference Brands: Vabysmo (USA/EU)

View Details
Ranibizumab

Strength:
10 mg/mL

Form: Injection

Reference Brands: Lucentis (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.